Controlled Release Drug Delivery Market Worth USD 90.18 Billion By 2025: Grand View Research,Inc.

Posted on 2018-07-25 by researchinsights in Pharmaceuticals // 0 Comments

The global Controlled Release Drug Delivery Market size is expected to reach USD 90.18 billion by 2025, according to a new report by Grand View Research, Inc., registering a 13.8% CAGR during the forecast period. Some of the key factors accelerating market growth are needed for alternative therapies, need for these systems for geriatric and pediatric use, and benefits offered by these technologies over conventional forms of drug delivery.

Controlled release drug delivery technologies offer various benefits over traditional medication delivery methods. Reduced dosage, lower dosage frequency, fewer adverse gastrointestinal effects, enhanced patient compliance, uniform drug effect, improved efficacy and safety of the medication, and reduction in fluctuation of plasma drug levels are some of the benefits offered by these technologies. With an increase in R&D by various pharmaceutical companies, there has been a rise in the adoption of these systems.

The North American region accounted for the largest market revenue share due to technologically advanced infrastructure, increasing R&D, and presence of major players and pharmaceutical companies in the region. The Asia Pacific region is anticipated to register the highest CAGR during the forecast period. Emerging countries such as China and India are expected to witness strong growth through 2025 owing to the adoption of enhanced healthcare infrastructure and medical technologies for specialized patient care.

To request a sample copy summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market

Further key findings from the study suggest:

Oral controlled release drug delivery systems held the largest market share owing to increase in usage and ease of convenience offered for the administration of medication
Targeted drug delivery is anticipated to exhibit the highest CAGR during the forecast period owing to its various benefits and increasing adoption
Osmotic drug delivery is expected to emerge as the fastest growing segment due to its ability to not be affected by various factors such as pH, food consumption, and gastrointestinal motility
The North American region held the largest revenue share due to the local presence of major market players and increasing R&D in the field to cater to a rising number of patients
The Asia Pacific region is expected to showcase the highest CAGR during the forecast period owing to rising investments by dominant players in the region and developments in the pharmaceutical industry in emerging countries such as India and China.

Related Report of Electronics & Semicon:

Grand View Research has segmented the global controlled release drug delivery market on the basis of technology, release mechanism, application, and region:

Controlled Release Drug Delivery Technology Outlook (Revenue, USD Billion, 2014 – 2025)

Wurster Technique
Coacervation
Microencapsulation
Implants
Transdermal
Targeted Delivery
Others

Controlled Release Drug Delivery Release Mechanism Outlook (Revenue, USD Billion, 2014 – 2025)

Polymer Matrix Based Systems
Micro Reservoir Partition Controlled Drug Delivery Systems
Feedback Regulated Drug Delivery Systems
Activation-modulated Drug Delivery Systems
Chemically Activated

Controlled Release Drug Delivery Application Outlook (Revenue, USD Billion, 2014 – 2025)

Metered Dose Inhalers
Injectable
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-Drug Delivery Systems
Drug Eluting Stents

Controlled Release Drug Delivery Regional Outlook (Revenue, USD Billion, 2014 – 2025)

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Italy
- Spain
Asia Pacific
- Japan
- China
- India
Latin America
- Brazil
- Mexico
MEA
- South Africa
- Saudi Arabia

Access Press Release of This Research Report by Grand View Research: www.grandviewresearch.com/press-release/global-controlled-release-drug-delivery-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Matched content

Editor’s pick